HealthTech Bridge Launches to Boost International HealthTech Access

On March 5, 2026, the launch of HealthTech Bridge marks a significant advancement in the field of health technology. This program is designed to facilitate the entry of international health technology companies into the U.S. market by providing essential clinical validation and commercialization support.

Developed by HTA and Venture Atlas Labs, HealthTech Bridge connects international innovators with prominent U.S. clinical partners, offering opportunities for evidence generation and strategic market access. The inaugural initiative, known as the Rural Health Program, will soon open for applications.

Tailored Support for International Innovators

HealthTech Bridge is specifically created to address the unique challenges faced by international health technology companies. It combines clinical engagement with comprehensive commercialization guidance. Participating companies will engage in structured clinical validation through pilot studies and real-world evaluations with provider partners.

As Elizabeth Jennings, Managing Partner of Venture Atlas Labs, emphasized, entering the U.S. market requires a fundamental reevaluation of commercialization strategies. “The U.S. healthcare system is complex, opaque, and often unforgiving to business models designed elsewhere,” she stated. “Through HealthTech Bridge, we’re helping founders pressure-test their strategy in real time, so they can enter the market with confidence and clarity.”

Jeff Stinson, Director of HTA, also highlighted the importance of clinical evidence in healthcare innovation. He remarked, “HealthTech Bridge is designed to help international founders not just understand the U.S. market, but generate the clinical proof and provider partnerships that accelerate adoption, reimbursement, and investor confidence.”

Addressing Rural Health Challenges

The Rural Health Program, the first initiative under HealthTech Bridge, focuses on innovations aimed at enhancing cardiometabolic health in rural areas. Rural communities often face significant barriers, including workforce shortages and limited access to care. The program seeks to facilitate clinical evaluations and pilot implementations in these underserved settings, allowing companies to generate valuable evidence where health technology can make a tangible impact.

Participating organizations will gain early access to real-world data and feedback, which can inform product development, deployment strategies, and future commercial partnerships. HealthTech Bridge is tailored for startups and scaleups that have shown traction outside the United States but require assistance navigating the clinical, regulatory, and commercial complexities of the U.S. healthcare landscape.

The program offers a structured curriculum focused on international needs, mentorship from experienced healthcare leaders, facilitated clinical studies with U.S. providers, and connections to investors.

The launch of HealthTech Bridge builds on HTA’s track record of fostering real-world clinical partnerships and research collaborations. Through its flagship program, HeartX, HTA guarantees clinical pilots and studies for participants by collaborating directly with major hospitals and health systems.

For more information about HealthTech Bridge and the upcoming Rural Health Program, interested parties can visit healthtechbridge.com.

HTA is committed to driving innovation in healthcare through its accelerator programs. The organization has a history of supporting cardiovascular-focused startups in digital health, medical devices, and diagnostic platforms. Venture Atlas Labs plays a crucial role in helping healthcare innovators scale into the U.S. and European markets, providing critical support in health economics and regulatory structuring.